PATENT CLAIM ANALYSIS

Application Number: 15987506
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "278000"]

Abstract:
This invention relates to compounds that are agonists of the muscarinic M 1  receptor and which are useful in the treatment of muscarinic M 1  receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where m, p, q, W, Z, Y, X 1 , X 2 , R 1 , R 2 , R 3  and R 4  are as defined herein.

Claim (Index 30):
A method of treating dementia in a subject, comprising administering an effective amount of the compound according to  claim 22  to the subject in need thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 93.0
- Lexical Diversity: 1.80851
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15126935', '15559375', '15595107', '14428927', '15980278']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7933792966045394
- 35 USC 102 Novelty (BERT): 0.6065475067993479
- Combined Prediction Score: 0.7746961176240202
- Mean Citation Score: 474.02373
- Max Citation Score: 591.03076
- Similarity Product: 447.6806435531688

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test